JPMorgan Chase & Co’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
16,034
+1,328
| +9% | +$8.92K | ﹤0.01% | 4761 |
|
|
2025
Q1 | $133K | Sell |
14,706
-20,764
| -59% | -$188K | ﹤0.01% | 4609 |
|
|
2024
Q4 | $613K | Buy |
35,470
+24,658
| +228% | +$426K | ﹤0.01% | 4056 |
|
|
2024
Q3 | $173K | Buy |
10,812
+242
| +2% | +$3.87K | ﹤0.01% | 4517 |
|
|
2024
Q2 | $151K | Buy |
10,570
+2,157
| +26% | +$30.7K | ﹤0.01% | 4404 |
|
|
2024
Q1 | $119K | Sell |
8,413
-5,741
| -41% | -$81.4K | ﹤0.01% | 4668 |
|
|
2023
Q4 | $214K | Sell |
14,154
-427
| -3% | -$6.44K | ﹤0.01% | 4418 |
|
|
2023
Q3 | $230K | Sell |
14,581
-2,069
| -12% | -$32.7K | ﹤0.01% | 4159 |
|
|
2023
Q2 | $252K | Buy |
16,650
+8,110
| +95% | +$123K | ﹤0.01% | 4159 |
|
|
2023
Q1 | $124K | Buy |
8,540
+947
| +12% | +$13.8K | ﹤0.01% | 4561 |
|
|
2022
Q4 | $103K | Buy |
+7,593
| New | +$103K | ﹤0.01% | 4489 |
|
|
2022
Q2 | – | Sell |
-4,934
| Closed | -$46K | – | 5917 |
|
|
2022
Q1 | $46K | Buy |
4,934
+1,440
| +41% | +$13.4K | ﹤0.01% | 5039 |
|
|
2021
Q4 | $60K | Buy |
+3,494
| New | +$60K | ﹤0.01% | 5012 |
|